Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies
A.B. Gottlieb; J.‐P. Lacour; N. Korman; S. Wilhelm; Y. Dutronc; A. Schacht; J. Erickson; L. Zhang; L. Mallbris; S. Gerdes
Author Information: Department of Dermatology New York Medical College
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.